Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05052580 · ClinicalTrials.gov registry record · NA

Test to Stay in School: COVID-19 Testing Following Exposure in School Communities

A NA study of Covid19, sponsored by Duke University.

Completed
Registry status
NA
Development phase
4,733
Enrollment target
1
Study location

NCT05052580 is a NA study of Covid19 that has completed, run by Duke University. The registered enrollment target is 4,733 participants, above the 2,652-participant average among 94 other Covid19 trials with a reported enrollment target (78% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05052580, a NA study of Covid19, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
4,733 participants
Enrollment target
1
Study location

Study Summary

Participants in school communities who have been exposed to SARS-CoV-2 will be tested for COVID-19 on the day of exposure (day 1) and at days 3, 5, and 7 following initial known exposure. Mitigation practices including masking, the context of exposure (classroom, school bus, after school sporting event, lunch, etc.), and results of COVID-19 test will be documented.

Conditions Studied

Interventions

  • OTHER COVID-19 Testing

Study Locations (1)

North Carolina

  • Participating NC School Districts - Durham

Trial Details

FieldValue
Enrollment Target 4,733 participants
Start Date 2021-10-01
Est. Completion 2022-03-28
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT05052580

The ClinicalTrials.gov registry entry for NCT05052580 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 4,733 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,652-participant average among 94 other Covid19 trials with a reported enrollment target (78% higher). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Covid19 appearing as the primary indexed condition, and to 1 intervention - of which COVID-19 Testing is the first listed.

NCT05052580 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT05052580 about?

NCT05052580 is a clinical study titled "Test to Stay in School: COVID-19 Testing Following Exposure in School Communities". Participants in school communities who have been exposed to SARS-CoV-2 will be tested for COVID-19 on the day of exposure (day 1) and at days 3, 5, and 7 following initial known exposure. Mitigation practices including masking, the context of exposure (classroom, school bus, after school sporting ev...

What is the current status of trial NCT05052580?

This trial is currently completed. It is a NA study. The enrollment target is 4,733 participants. The study started on 2021-10-01. Estimated completion is 2022-03-28.

What conditions does trial NCT05052580 study?

This clinical trial studies the following conditions: Covid19.

What interventions are being tested in trial NCT05052580?

The interventions under investigation include: COVID-19 Testing (OTHER).

Who is sponsoring clinical trial NCT05052580?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05052580 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Covid19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.